This is clinically relevant, as shown in patients with coronary artery disease in whom a greater number of guanosine thymidine dinucleotide repeats in the HO-1 promoter was found to be associated with a greater risk for chronic kidney disease (CKD) [85]. This evidence concerns the gene HMOX1 and chronic kidney disease.